Safety, efficacy, and immunogenicity of an inactivated influenza vaccine in healthy adults: a randomized, placebo-controlled trial over two influenza seasons

Overview of attention for article published in BMC Infectious Diseases, March 2010

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (94th percentile)
High Attention Score compared to outputs of the same age and source (92nd percentile)

Mentioned by

news: 1 news outlet
policy: 1 policy source

twitter: 19 X users

Readers on

mendeley: 109 Mendeley

Summary News Policy documents X

So far, Altmetric has seen 2 news stories from 1 outlets.

Novavax: Earnings Call Review And Assessment Of The Multi-Arm RSV Trial

Seeking Alpha, 09 May 2017

I had to undergo surgery a few months ago and the recovery wiped out most of my time, so it's taken me much longer than…

Novavax; Part 2: A Deep Dive Into Phase 3 Of Its RSV Vaccine For Older Adults

Seeking Alpha, 20 Sep 2016

After Thursday's close, Novavax (NASDAQ: NVAX ) announced its phase 3 trial of its vaccine to prevent RSV (respiratory…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.